NovaBay Pharmaceuticals Inc Cash Flow Reinvestment Rate
NovaBay Pharmaceuticals Inc cash flow reinvestment rate. NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow Reinvestment Rate of 0.26x as of September 2017, reinvesting $73.00K (capex $73.00K ) from operating cash flow of $281.00K. Explore NBY operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NovaBay Pharmaceuticals Inc (2006–2010)
Cash flow reinvestment rate of NovaBay Pharmaceuticals Inc from 2006 to 2010. Historical reinvestment intensity for NovaBay Pharmaceuticals Inc across 2 annual periods. Explore capital reinvestment ratio of NovaBay Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
NovaBay Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2006–2010)
NovaBay Pharmaceuticals Inc cash flow reinvestment rate by year from 2006 to 2010. Year-by-year capital reinvestment analysis for NovaBay Pharmaceuticals Inc. For the full cash flow conversion analysis, see NovaBay Pharmaceuticals Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.10x | $203.00K | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $362.00K | $4.74 Million | $362.00K | — |